Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank85
3Y CAGR+7.5%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+7.5%/yr
vs +22.9%/yr prior
Acceleration
-15.4pp
Decelerating
Percentile
P85
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 47.46% |
| 2024 | -17.70% |
| 2023 | -33.46% |
| 2022 | 38.19% |
| 2021 | -28.17% |
| 2020 | -12.05% |
| 2019 | 61.26% |
| 2018 | 16.72% |
| 2017 | 11495.05% |
| 2016 | 0.00% |